A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...

As politicians, activists and researchers duke it out from labs and clinics and press conferences, those who have the most to ...

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...

Gilead's HIV drug lenacapavir earns FDA priority review after strong trial results, with the company planning to double U.S.

Nina E. Hill, MD, from the University of Michigan in Ann Arbor, and colleagues examined recent trends in HIV PrEP among young adults (aged 18 to 25 years). The analysis included data from the IQVIA ...

AVOL Kentucky told us there was concern about proposed budget cuts at the federal level. Those cuts are now reality after the ...

The PURPOSE trials illuminated the ways in which lenacapavir could be used as a means of pre-exposure prophylaxis effectively, but also featured several adverse events.

PrEP is credited with helping drive down HIV infections – but a lawsuit now before the U.S. Supreme Court could end insurance ...

As Australians, we get proactive health. Our response to the HIV/AIDS epidemic led the world. “Slip, slop, slap” has become ...

In a third-grade classroom exercise, Patrick Kelly wrote that he wanted to become a scientist when he grew up. With that ...

June is a special month for enjoying the warmer days and the official start of summer. In fact, the first day of summer is ...